- Home
- LICY vs PASG Comparison
LICY vs PASG Comparison
Compare LICY & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LICY
- PASG
- Stock Information
- Founded
- LICY 2016
- PASG 2017
- Country
- LICY Canada
- PASG United States
- Employees
- LICY N/A
- PASG N/A
- Industry
- LICY Environmental Services
- PASG Biotechnology: Pharmaceutical Preparations
- Sector
- LICY Industrials
- PASG Health Care
- Exchange
- LICY Nasdaq
- PASG Nasdaq
- Market Cap
- LICY 35.8M
- PASG 42.2M
- IPO Year
- LICY N/A
- PASG 2020
- Fundamental
- Price
- LICY $0.91
- PASG $0.52
- Analyst Decision
- LICY Hold
- PASG Strong Buy
- Analyst Count
- LICY 2
- PASG 3
- Target Price
- LICY $4.13
- PASG $8.00
- AVG Volume (30 Days)
- LICY 1.3M
- PASG 136.2K
- Earning Date
- LICY 03-14-2025
- PASG 03-03-2025
- Dividend Yield
- LICY N/A
- PASG N/A
- EPS Growth
- LICY N/A
- PASG N/A
- EPS
- LICY N/A
- PASG N/A
- Revenue
- LICY $27,400,000.00
- PASG N/A
- Revenue This Year
- LICY $61.64
- PASG N/A
- Revenue Next Year
- LICY $21.35
- PASG N/A
- P/E Ratio
- LICY N/A
- PASG N/A
- Revenue Growth
- LICY N/A
- PASG N/A
- 52 Week Low
- LICY $0.77
- PASG $0.45
- 52 Week High
- LICY $15.36
- PASG $1.79
- Technical
- Relative Strength Index (RSI)
- LICY 38.36
- PASG 39.73
- Support Level
- LICY $0.77
- PASG $0.52
- Resistance Level
- LICY $1.05
- PASG $0.60
- Average True Range (ATR)
- LICY 0.08
- PASG 0.05
- MACD
- LICY 0.04
- PASG 0.00
- Stochastic Oscillator
- LICY 48.06
- PASG 20.37
About LICY Li-Cycle Holdings Corp.
Li-Cycle Holdings Corp is a lithium-ion battery resource recovery and lithium-ion battery recycler. The company's proprietary process Spoke and Hub recycling process is designed at its Spokes, to process battery manufacturing scrap and end-of-life batteries to produce black mass and other intermediate products, and at its Hubs, to process black mass to recover raw materials, including but not limited to lithium carbonate, cobalt sulphate, and nickel sulphate.
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.